Acute generalized exanthematous pustulosis from dalteparin.
Heparins are widely used for the prophylaxis and treatment of venous thromboembolism. Several types of immunologically mediated reactions to heparins are reported, among them delayed-type hypersensitivity reactions with erythematous, infiltrated itchy plaques at injection sites. We describe a female patient, whose localized reaction from dalteparin was followed by a generalized rash presenting as acute generalized exanthematous pustulosis. Subcutaneous provocation testing showed cross-reactions to enoxaparin, certoparin, reviparin, nadroparin, danaparoid, fondaparinux, but not to pentosan polysulfate. The danaparoid and in a lesser extent the nadroparin patch showed pustules. Within the next day, a generalized rash developed. The upper aspect of her trunk was highly affected and showed discrete pustules. Despite the fact that low molecular-weight heparins are widely prescribed, this is, to our knowledge, the first observation of a pustular drug eruption attributable to this class of substances.
Komericki
Peter
P
Department for Environmental Dermatology and Venereology, Medical University of Graz, Graz, Austria. peter.komericki@meduni-graz.at
Grims
Robert
R
Kränke
Birger
B
Aberer
Werner
W
D000208:Acute Disease; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D017985:Dalteparin / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions; D005076:Exanthema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007267:Injections; D008875:Middle Aged; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced*; D012882:Skin Tests; D013924:Thrombophlebitis / Q000188:drug therapy
D000925:Anticoagulants; D017985:Dalteparin